Compare Cronos Group Inc (CRON) vs J M Smucker Co (SJM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cronos Group Inc vs J M Smucker Co — how do they compare? Cronos Group Inc trades at $3.24 (market cap $1.18B), while J M Smucker Co trades at $120.56 (market cap $12.76B). The key difference: J M Smucker Co is far larger — about 10.8× Cronos Group Inc's market cap, and J M Smucker Co pays a 3.75% dividend while Cronos Group Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Cronos Group Inc for 22 Days and J M Smucker Co for 74 Days on average.
| CRON | SJM | |
|---|---|---|
Market Cap | $1.18B | $12.76B |
Volume | 968,037 | 1,300,545 |
Sector | Health | Consumer Staples |
52-Week High | $3.55 | $132.34 |
52-Week Low | $2.30 | $89.53 |
Typical Hold Time | 22 Days | 74 Days |
Enterprise Value | $387.62M | $19.61B |
Dividend Yield | — | 3.75% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
CRON trades at $3.24, down 1.37% today amid a bearish technical signal. Recent quarterly earnings show beats in Q1 and Q2 2026, with revenue growth from $118M in 2024 to $147M in 2025. The company reported a net loss of $9.45M in 2025 but projects a profit of $70M for 2026. Analyst sentiment is mixed with a 20% buy rating. News highlights focus on international expansion and a recent Investor Day outlining growth strategies.
Outlook is cautiously optimistic given projected profitability in 2026 and strong cash reserves, but risks include sustained negative cash flow and competitive pressures. The stock's valuation metrics like P/E of 16.95 and P/S of 6.84 suggest moderate pricing relative to peers, though high EV/EBITDA of 43 indicates premium expectations.
SJM trades at $115.93, down 0.74% on the day, with a bearish technical signal. The company reported a net loss of $1.23 billion in 2025 despite revenue growth to $8.73 billion, though recent quarters have beaten EPS estimates. Analyst consensus is a Buy with a $137.29 price target, and a dividend of $1.12 is scheduled for September 2026.
The outlook is mixed: strong recent earnings beats and positive analyst sentiment suggest upside, but high P/E of 54.17 and volatile profitability pose risks. Key opportunities include raised FY2027 guidance and brand strength, while risks involve margin pressure and high debt levels impacting shareholder value.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Cronos Group Inc
Cronos Group, headquartered in Toronto, Canada cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis to Poland and Germany. In addition, it has entered joint ventures in Israel, Colombia, and Australia to drive further international cultivation and distribution growth. In the U.S. the company directly sells hemp-derived CBD and has an option to acquire 10.5% of U.S. multistate operator PharmaCann.
Read more on CRON →About J M Smucker Co
J.M. Smucker is a packaged food company that primarily operates in the U.S. retail channel (87% of fiscal 2022 revenue), but also in U.S. food-service (7%), and international (6%). Its largest segment is pet food and treats (36% of 2022 revenue), with popular brands such as Milk-Bone, Meow Mix, 9Lives, Kibbles 'n Bits, Nature's Recipe, and Rachael Ray Nutrish. Its second-largest category is coffee (35% across channels) with the number-two brand Folgers and number-six Dunkin'. Other large categories are peanut butter (10%), with number-one Jif, fruit spreads (5%) with number-one Smucker's, and frozen hand-held foods (6%) with number-one Uncrustables.
Read more on SJM →
